Jean-Francois Formela
Co-Founder & DirectorDr. Jean-François Formela M.D., MBA, is a Partner at Atlas Venture Advisors, Inc. (formerly known as Atlas Venture L.P.). He joined Atlas Venture in 1993 to build the U.S. life sciences franchise. He is a Director and co-founder of IFM Therapeutics and Korro Bio (NASDAQ: KRRO) and serves on the boards of Antares Therapeutics, Ikena Oncology (NASDAQ: IKNA) and Triveni Bio, as well as several stealth companies. He was also a co-founder and director of Intellia Therapeutics (NASDAQ: NTLA) and Translate Bio (acquired by Sanofi). In addition to his investment roles, Dr. Formela is a member of the Mass General Brigham Innovation Advisory Board and a former trustee of the Boston Institute of Contemporary Art. Dr. Formela has extensive experience in managing corporate financial functions and merger and acquisition transactions, having previously served as Senior Director of Medical Marketing and Scientific Affairs at Schering-Plough Corporation. He began his career as a medical doctor practicing emergency medicine at Necker University Hospital in Paris. He received his M.D. from Paris University School of Medicine and his M.B.A. from Columbia University.
Positions
- Company NameKorro Bio, Inc.Stock CodeKRROPositionCo-Founder & DirectorColleagues
- RARam AiyarCEO, President, Interim CFO, Principal Financial Officer & Director
- NBNessan BerminghamCo-Founder & Independent Chairman of the Board
- LVLoic VincentChief Scientific Officer
- JMJeffrey M. CerioSenior VP, General Counsel & Corporate Secretary
- AFAndrew FraleyCo-Founder & Advisor
- ABAli BehbahaniIndependent Director
- TRTimothy R. PearsonIndependent Director
